OTC: SEOVF - Sernova Corp.

Yield per half year: -35%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Sernova Corp.


About Sernova Corp.

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

more details
Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells;a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform; and research collaboration with AstraZeneca PLC to evaluate novel potential therapeutic cell applications. The company was incorporated in 1998 and is headquartered in London, Canada.

IPO date 1999-04-12
ISIN CA81732W1041
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.sernova.com
Цена ао 0.11
Change price per day: 0% (0.13)
Change price per week: 0% (0.13)
Change price per month: +8.33% (0.12)
Change price per 3 month: -13.33% (0.15)
Change price per half year: -35% (0.2)
Change price per year: -61.76% (0.34)
Change price per 3 year: -89.34% (1.22)
Change price per 5 year: +73.33% (0.075)
Change price per year to date: -18.75% (0.16)

Underestimation

Title Value Grade
P/S 0 0
P/BV -5.93 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -217.26 0
ROE, % 14564.17 10
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 559.42 10
Yield EPS, % 387.46 10
Total: 8



Head Job title Payment Year of birth
Mr. Christopher Barnes Vice President of Investor Relations 119.98k
Dr. Frank Shannon M.D. Vice President of Clinical Development & Regulatory Affairs 255.85k
Ms. Cynthia Pussinen CEO & Director 404.17k
Mr. Douglas Maret Chief Science Officer N/A
Dr. Modestus Obochi M.B.A., Ph.D. Chief Business Officer 221.36k
Mr. Nicholas J. Rossettos CPA, M.B.A. Interim Chief Financial Officer N/A 1966 (59 years)
Mr. Jonathan M. N. Rigby M.B.A., MBA Executive Chairman 1968 (57 years)

Address: Canada, London, The Stiller Centre - open in Google maps, open in Yandex maps
Website: https://www.sernova.com